Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Celltrion, Inc.
Case Number: 1:2024cv00053
Filed: May 17, 2024
Court: US District Court for the Northern District of West Virginia
Presiding Judge: Thomas S Kleeh
Nature of Suit: Patent
Cause of Action: 35 U.S.C. ยง 145 Patent Infringement
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on May 20, 2024. A more recent docket listing may be available from PACER.

Date Filed Document Text
May 20, 2024 Filing 5 Corporate Disclosure Statement by Regeneron Pharmaceuticals, Inc.. (Ruby, Steven)
May 20, 2024 Filing 4 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. Copy to Trademark/Patent Office. (hrc) (Main Document 4 replaced on 5/20/2024) (hrc).
May 20, 2024 Filing 2 VERIFICATION OF ATTORNEY ADMISSION as to A. Pan, A. Goldsmith, A. Trask, A. Desai, A. Argall III, C. Pepe, D. Berl, E. Weisswasser, E. Oberwetter, E. Leo, H. Anderson, J. Hartman, J. Beazley, J. Crozier, K. Kayali, K. Leicht, M. Carroll, M. Sieger, N. Kennedy, P. Patel, R. Griffin, R. Recce, S. Mahaffy, S. Henningson III, T. Gregory, T. Fletcher, T. Yu, Y. Zhang and Z. Lin. (hrc)
May 17, 2024 Filing 1 COMPLAINT against Celltrion, Inc., filed by Regeneron Pharmaceuticals, Inc. Filing Fee $405: Receipt #AWVNDC-3945895. (Attachments: #1 Civil Cover Sheet, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16, #18 Exhibit 17, #19 Exhibit 18, #20 Exhibit 19, #21 Exhibit 20, #22 Exhibit 21, #23 Exhibit 22, #24 Exhibit 23, #25 Exhibit 24, #26 Exhibit 25, #27 Exhibit 26, #28 Exhibit 27)(hrc)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the West Virginia Northern District Court's Electronic Court Filings (ECF) System

Search for this case: Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Regeneron Pharmaceuticals, Inc.
Represented By: Adam Pan
Represented By: Andrew E. Goldsmith
Represented By: Andrew V. Trask
Represented By: Anish R Desai
Represented By: Arthur J. Argall, III
Represented By: Christopher M. Pepe
Represented By: David I. Berl
Represented By: David R. Pogue
Represented By: Elizabeth Stotland Weiswasser
Represented By: Ellen E. Oberwetter
Represented By: Evan T. Leo
Represented By: Haylee Bernal Anderson
Represented By: Jacob E. Hartman
Represented By: Jennalee Beazley
Represented By: Jennifer Melien Brooks Crozier
Represented By: Kathryn S. Kayali
Represented By: Kathryn Leicht
Represented By: Mary Charlotte Y. Carroll
Represented By: Matthew D. Sieger
Represented By: Natalie C. Kennedy
Represented By: Priyata Y. Patel
Represented By: Raymond S Franks, II
Represented By: Renee M. Griffin
Represented By: Rocco Recce
Represented By: Shaun P. Mahaffy
Represented By: Steven Robert Ruby
Represented By: Sven Eric Henningson, III
Represented By: Yi Zhang
Represented By: Teagan J. Gregory
Represented By: Thomas S. Fletcher
Represented By: Tom Yu
Represented By: Zhen Lin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Celltrion, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?